Literature DB >> 24569228

Regulation of microRNAs in cancer metastasis.

Juliette M C Bouyssou1, Salomon Manier2, Daisy Huynh2, Samar Issa3, Aldo M Roccaro2, Irene M Ghobrial4.   

Abstract

Metastasis is a phenomenon of crucial importance in defining prognosis in patients with cancer and is often responsible for cancer-related mortality. It is known that several steps are necessary for clonal cells to disseminate from their primary tumor site and colonize distant tissues, thus originating metastatic lesions. Therefore, investigating the molecular actors regulating this process may provide helpful insights in the development of efficient therapeutic responses. Recent evidences have indicated the role of microRNAs (miRNAs) in modulating the metastatic process in solid tumors. miRNAs are small regulatory non-coding RNAs that bind to specific target mRNAs, leading to translational repression. miRNAs are known to act as negative regulators of gene expression and are involved in the regulation of biological processes, including cell growth, differentiation and apoptosis, both in physiological conditions and during diseases, such as tumors. In the specific field of tumorigenesis, miRNAs play an important role in mediating oncogenesis and favoring tumor progression, as a result of their ability to modulate epithelial-to-mesenchymal transition (EMT) and other series of events facilitating the formation of metastasis. The role of miRNAs in cancer development has been widely studied and has helped elucidate events such as the change in expression of oncogenes, tumor-suppressors and cancer-related proteins. This review focuses on the mechanisms underlying the role of miRNAs as part of the metastatic process.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; EMT; Epigenetics; Metastasis; MicroRNAs

Mesh:

Substances:

Year:  2014        PMID: 24569228      PMCID: PMC4170185          DOI: 10.1016/j.bbcan.2014.02.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  197 in total

1.  MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.

Authors:  Regalla Kumarswamy; Giridhar Mudduluru; Paolo Ceppi; Santoshi Muppala; Miroslaw Kozlowski; Jacek Niklinski; Mauro Papotti; Heike Allgayer
Journal:  Int J Cancer       Date:  2011-08-08       Impact factor: 7.396

2.  MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein.

Authors:  Yanhui Lou; Xingsheng Yang; Fuling Wang; Zhumei Cui; Yu Huang
Journal:  Int J Mol Med       Date:  2010-12       Impact factor: 4.101

3.  MiR-9 downregulates CDX2 expression in gastric cancer cells.

Authors:  Pichayanoot Rotkrua; Yoshimitsu Akiyama; Yutaka Hashimoto; Takeshi Otsubo; Yasuhito Yuasa
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

Review 4.  MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.

Authors:  H Xia; K M Hui
Journal:  Cancer Gene Ther       Date:  2012-09-14       Impact factor: 5.987

5.  Nucleolin protein interacts with microprocessor complex to affect biogenesis of microRNAs 15a and 16.

Authors:  Brian F Pickering; Dihua Yu; Michael W Van Dyke
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

6.  BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

Authors:  Aldo M Roccaro; Antonio Sacco; Patricia Maiso; Abdel Kareem Azab; Yu-Tzu Tai; Michaela Reagan; Feda Azab; Ludmila M Flores; Federico Campigotto; Edie Weller; Kenneth C Anderson; David T Scadden; Irene M Ghobrial
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

7.  Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.

Authors:  Sijin Liu; Robert H Goldstein; Ellen M Scepansky; Michael Rosenblatt
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

8.  Identifying mRNA, microRNA and protein profiles of melanoma exosomes.

Authors:  Deyi Xiao; Joanna Ohlendorf; Yinlu Chen; Douglas D Taylor; Shesh N Rai; Sabine Waigel; Wolfgang Zacharias; Hongying Hao; Kelly M McMasters
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

9.  MicroRNA-143 inhibits migration and invasion of human non-small-cell lung cancer and its relative mechanism.

Authors:  Qingping Ma; Qianqian Jiang; Qiang Pu; Xuechao Zhang; Weihan Yang; Yu Wang; Sujuan Ye; Shifei Wu; Guoxing Zhong; Jiang Ren; Yan Zhang; Lunxu Liu; Wen Zhu
Journal:  Int J Biol Sci       Date:  2013-07-18       Impact factor: 6.580

10.  Selective blockade of microRNA processing by Lin28.

Authors:  Srinivas R Viswanathan; George Q Daley; Richard I Gregory
Journal:  Science       Date:  2008-02-21       Impact factor: 47.728

View more
  84 in total

1.  Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2.

Authors:  A Kroiss; S Vincent; M Decaussin-Petrucci; E Meugnier; J Viallet; A Ruffion; F Chalmel; J Samarut; N Allioli
Journal:  Oncogene       Date:  2014-07-28       Impact factor: 9.867

2.  MicroRNA-330-3p functions as an oncogene in human esophageal cancer by targeting programmed cell death 4.

Authors:  Hui Meng; Kai Wang; Xuedan Chen; Xingying Guan; Liwen Hu; Gang Xiong; Juan Li; Yun Bai
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

3.  Enhanced expression of long noncoding RNA CARLo-5 is associated with the development of gastric cancer.

Authors:  Yan Zhang; Mingzhe Ma; Weiyong Liu; Wenping Ding; Honggang Yu
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

4.  miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM.

Authors:  Sihai Yue; Lihua Wang; Hui Zhang; Youhui Min; Yongli Lou; Hongshan Sun; Yu Jiang; Wenjin Zhang; Aming Liang; Yongkun Guo; Ping Chen; Guowei Lv; Liuxiang Wang; Qinghua Zong; Yong Li
Journal:  Tumour Biol       Date:  2015-04-03

Review 5.  Long Non-coding RNAs and their Role in Metastasis.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwen Kollmorgen; Rüdiger Rüger
Journal:  Cancer Genomics Proteomics       Date:  2017 May-Jun       Impact factor: 4.069

Review 6.  Role of MicroRNA Regulation in Obesity-Associated Breast Cancer: Nutritional Perspectives.

Authors:  Ravi Kasiappan; Dheeran Rajarajan
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

7.  Serum microRNA-128 as a biomarker for diagnosis of glioma.

Authors:  Jun Sun; Keman Liao; Xuechao Wu; Jin Huang; Shuai Zhang; Xiaojie Lu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

8.  miR30a inhibits LOX expression and anaplastic thyroid cancer progression.

Authors:  Myriem Boufraqech; Naris Nilubol; Lisa Zhang; Sudheer Kumar Gara; Samira M Sadowski; Amit Mehta; Mei He; Sean Davis; Jennifer Dreiling; John A Copland; Robert C Smallridge; Martha M Quezado; Electron Kebebew
Journal:  Cancer Res       Date:  2014-12-08       Impact factor: 12.701

9.  MiR-101 regulates apoptosis of trophoblast HTR-8/SVneo cells by targeting endoplasmic reticulum (ER) protein 44 during preeclampsia.

Authors:  Y Zou; Z Jiang; X Yu; Y Zhang; M Sun; W Wang; Z Ge; W De; L Sun
Journal:  J Hum Hypertens       Date:  2014-05-08       Impact factor: 3.012

10.  MicroRNA-196a2 Biomarker and Targetome Network Analysis in Solid Tumors.

Authors:  Eman A Toraih; Manal S Fawzy; Eman A Mohammed; Mohammad H Hussein; Mohamad M El-Labban
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.